Literature DB >> 20470693

[Myofascial pain syndrome in the pelvic floor: a common urological condition].

F Itza1, D Zarza, L Serra, F Gómez-Sancha, J Salinas, A Allona-Almagro.   

Abstract

INTRODUCTION: Myofascial pain syndrome in the pelvic floor is a very common condition in the urological field and is often ignored or misdiagnosed.
OBJECTIVES: To present the prevalence of this syndrome to professionals of urology through a systematic review of existing literature and its potentials for diagnosis and treatment.
MATERIALS AND METHODS: We performed a literature search through the database "Pubmed" using the terms "Trigger points", "myofascial pain", "referred pain", "infiltrations" and "physical therapy", to which we add the term "pelvic floor". Then, we select the works in English, Spanish and French that we might like.
RESULTS: We develop the highlights of the syndrome: anatomy, etiology, anatomical-clinical correlation, epidemiology, perpetuating factors, diagnosis, medical therapy and physiotherapy treatment.
CONCLUSION: It is the most common cause of pain in the pelvic floor and greatly affects quality of life of patients. Nowadays, we have diagnostic and therapeutic tools that allow us to treat this disabling syndrome with good results.

Entities:  

Mesh:

Year:  2010        PMID: 20470693

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  10 in total

Review 1.  Psychological factors in chronic pelvic pain in women: relevance and application of the fear-avoidance model of pain.

Authors:  Meryl J Alappattu; Mark D Bishop
Journal:  Phys Ther       Date:  2011-08-11

Review 2.  Myofascial pelvic pain.

Authors:  Rhonda Kotarinos
Journal:  Curr Pain Headache Rep       Date:  2012-10

Review 3.  Interventional treatment for myofascial pelvic floor pain in women: systematic review with meta-analysis.

Authors:  Claudia Pignatti Frederice; Luiz Gustavo Oliveira Brito; Glaucia Miranda Varella Pereira; Anna Lygia Barbosa Lunardi; Cássia Raquel Teatin Juliato
Journal:  Int Urogynecol J       Date:  2021-02-27       Impact factor: 2.894

Review 4.  Recognizing myofascial pelvic pain in the female patient with chronic pelvic pain.

Authors:  Elizabeth A Pastore; Wendy B Katzman
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-08-03

5.  An International Survey of Commonly Used Interventions for Management of Pelvic Pain.

Authors:  Meryl Alappattu; Sandra Hilton; Mark Bishop
Journal:  J Womens Health Phys Therap       Date:  2019 Apr-Jun

6.  Turn-amplitude analysis as a diagnostic test for myofascial syndrome in patients with chronic pelvic pain.

Authors:  Fernando Itza; Daniel Zarza; Jesús Salinas; Fernando Teba; Carmen Ximenez
Journal:  Pain Res Manag       Date:  2015 Mar-Apr       Impact factor: 3.037

7.  Painful intercourse is significantly associated with evoked pain perception and cognitive aspects of pain in women with pelvic pain.

Authors:  Meryl J Alappattu; Steven Z George; Michael E Robinson; Roger B Fillingim; Nashat Moawad; Emily Weber LeBrun; Mark D Bishop
Journal:  Sex Med       Date:  2015-03       Impact factor: 2.491

Review 8.  Update on complications of synthetic suburethral slings.

Authors:  Cristiano Mendes Gomes; Fabrício Leite Carvalho; Carlos Henrique Suzuki Bellucci; Thiago Souto Hemerly; Fábio Baracat; Jose de Bessa; Miguel Srougi; Homero Bruschini
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

9.  Effectiveness of Hypopressive Exercises in Women with Pelvic Floor Dysfunction: A Randomised Controlled Trial.

Authors:  Beatriz Navarro-Brazález; Virginia Prieto-Gómez; David Prieto-Merino; Beatriz Sánchez-Sánchez; Linda McLean; María Torres-Lacomba
Journal:  J Clin Med       Date:  2020-04-17       Impact factor: 4.241

10.  Myofascial trigger points and innervation zone locations in upper trapezius muscles.

Authors:  Marco Barbero; Corrado Cescon; Andrea Tettamanti; Vittorio Leggero; Fiona Macmillan; Fiona Coutts; Roberto Gatti
Journal:  BMC Musculoskelet Disord       Date:  2013-06-08       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.